EMBER Industry Symposium 2017
College Court Conference Centre, Leicester, UK, 01 Nov 2017
The East Midlands Breathomics Pathology Node (EMBER) is developing novel breath-based systems for molecular pathology.
Hosted by the Leicester Precision Medicine Institute, the EMBER Industry Symposium will provide a forum for academia, practitioners from industry, and clinicians involved in breathomics and research across a wide range of clinical conditions including respiratory infections, cancers, respiratory disease such as asthma and chronic obstructive pulmonary disease, and cardiovascular disorders such as heart failure.
The purpose of this event is to explore ideas and understand how breathomics can be used and developed as a non-invasive approach for diagnosis, phenotyping and stratifying patients.
The event will include presentations and workshops from EMBER academics and clinicians as well as key guest speakers from industry partners.
Prof. Chris Brightling - NIHR Senior Investigator, Lead of NIHR Leicester BRC Respiratory Theme, EMBER, COPDMAP, AirPROM & ERS CRCs
Prof. Martin Tobin - Director LPMI and Professor of Genetic Epidemiology and Public Health
10:30 EMBER Discovery - Technology
Prof. Paul Monks - Pro Vice Chancellor and Head of College of Science and Engineering, University of Leicester
Prof. Paul Thomas - Professor of Analytical Science (Loughborough University), Lead of EMBER Workstream 2
11:10 Refreshment break
11:00 - 13:00
EMBER Discovery - Clinical Trials
Prof. Salman Siddiqui - Professor of Airways Disease and Respiratory Medicine, Lead of EMBER Workstream 4
EMBER Clinical Adoption
Mike Hannay - Managing Director of AHSN
EMBER Industry Partners
Billy Boyle - CEO of Owlstone Medical Ltd.
Prof. Jörg Ingo Baumbach - Professor of Analytical Chemistry & Toxicology, B&S Analytik (TBC)
13:00 Refreshment and lunch break
14:00 - 15:15 Let's talk EMBER
Workshop 1 - Technology development
Prof. Paul Thomas
Workshop 2 - Use of breath biomarker in drug trials
Prof. Salman Siddiqui
Workshop 3 - Use of breath biomarker in clinical trials
Prof. Chris Brightling
15:15 Summary and next steps
To meet with us at this event please get in touch.
For press information please contact:
Sarah Jeffery, Zyme Communications
+44 (0)7771 730919